Bristol Myers Squibb

Pharma company expects disruption to peak in second quarter

Regulator predicts GDP will increase by 4.8 per cent this year

Expert insight on hand from conference in Co Wicklow organised by Enterprise Ireland

Facebook led spending increases by Amazon.com, Apple, and Microsoft

Opvido was approved for head, neck and cancer treatment by the HSE in 2018

Industry, academia and State policies ensure life-sciences research prospers in Ireland

Takeover would gives Google access to a huge trove of heart rate, activity and sleep data

CSO to report retail spending figures. Alphabet, Facebook and Apple to deliver results

Committed companies are continually innovating to engage employees in their inclusion strategies

The biopharmaceutical firm has won multiple awards for its inclusive workplace policies

D&I must be embedded in a company’s culture and not just a lofty ambition on its mission statement

Bristol-Myers Squibb’s acquisition of Celgene goes ahead after Amgen pays €13.4bn for drug

Imfinzi with experimental drug tested on patients with advanced-stage cancer

Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland

Your business diary: Irish banks enter their reporting season under something of a cloud

Prominent Irish figures recall their memories of Neil Armstrong’s walk on the moon

Company desperate to fill gap for its blockbuster arthritis drug Humira which loses patent protection in 2023

Investors hedge bets ahead of expected US-China trade talks on sidelines of G20

Owner of Penneys and Primark brands to report interim results having previously anticipated first-half revenue growth in all its businesses

The Iseq all-share index rose just under 1.5%, buoyed by stocks with building exposure

Iseq rose 0.76%, buoyed by financials and CRH, outperforming peers

Intel, Ford and Starbucks to report; euro-zone consumer confidence flash also due

The move to buy Loxo Oncology is the second multibillion-dollar cancer deal of the year by a major US pharma giant

Iseq falls on thin trading volumes though Kerry Group ahead by 2.4 per cent

Transaction will be one of largest in history of pharma sector

For your diary: Euro zone consumer confidence due and 2018 EY Entrepreneur Of The Year winner

Nivolumab is potentially life-extending and can be used where chemotherapy has failed

Cancer strategy targets ‘to be missed’ if new generation drugs not backed by Government

Merck in the past has called the profitable animal health unit a ‘pillar of growth’

Business This Week: results, indicators and meetings

Cancer drugs feature in list of therapies waiting HSE approval on cost grounds

The three-year Great Place To Work Certification Programme provides the tools and techniques to build and sustain a high-performance culture in an organisation

Ryanair, Jones Lang LaSalle, Tullow Oil and Manchester United report results

New lower income-tax rate encourages US companies to repatriate billions of dollars in foreign profits held abroad

Bank of Ireland, PTSB and AIB rebound after ‘mauling’ over recent days

For Your Diary: EY Entrepreneur of the Year awards; CPL AGM; Irish retail sales

HSE approval means cost of nivolumab will be reimbursed for some treatments

Results from long-awaited Mystic lung cancer study fail to show hoped-for patient recovery

For your Diary: Ryanair, McDonald’s and the banks to reveal trading figures

SK Biotek, a South Korean company, will acquire the facility